OXALIPLATIN (Winthrop U.S.)
Welcome to the PulseAid listing for the OXALIPLATIN drug offered from Winthrop U.S.. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Winthrop U.S. |
NON-PROPRIETARY NAME: | oxaliplatin |
SUBSTANCE NAME: | OXALIPLATIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2014-07-07 |
END MARKETING DATE: | 0000-00-00 |
OXALIPLATIN HUMAN PRESCRIPTION DRUG Details:
Item Description | OXALIPLATIN from Winthrop U.S. |
LABELER NAME: | Winthrop U.S. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/mL) |
START MARKETING DATE: | 2014-07-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0955-1725_d8acf0f4-9a54-4b7d-86bb-848ea24e2b39 |
PRODUCT NDC: | 0955-1725 |
APPLICATION NUMBER: | NDA021759 |
Other OXALIPLATIN Pharmaceutical Manufacturers / Labelers: